On the other hand, 10% disagreed that the almanac covered all proposed topics, as it did not cover in depth the types of breast cancer such as HER2 positive or negative, triple negative, etc. However, these items were not included because this information should be provided by healthcare professionals in line with the protocol that will be followed, with the almanac being a support technology for the health education process. This evidence concerns the gene ERBB2 and breast cancer.